In 2024, Beroni Group and the School of Software, Tsinghua University officially reached a cooperation agreement to jointly develop the AI-based R&D Model. This cooperation marks the deep integration of…
Immune evasion has become one of the main obstacles in the development of tumor immunotherapy. In the field of invariant natural killer T（iNKT） cell therapy, CD1d in cancer cells is…
Recently, the research team of Beroni Group has successfully developed a technology that can transform human amniotic epithelial cells into neural stem cells. This innovative approach, which aims to generate…